AML
Showing 2501 - 2525 of 2,911
Hematological Malignancies Trial in Washington, Houston, Toronto (Obatoclax mesylate (GX15-070MS))
Completed
- Hematological Malignancies
- Obatoclax mesylate (GX15-070MS)
-
Washington, District of Columbia
- +2 more
May 9, 2014
Lymphoma, Multiple Myeloma, Leukemia Trial in Baltimore, Houston, Seattle (Busulfan, Fludarabine, Cytoxan)
Completed
- Lymphoma
- +3 more
- Busulfan, Fludarabine, Cytoxan
-
Baltimore, Maryland
- +2 more
Jan 29, 2015
Acute Myelogenous Leukemia, MDS Trial (AMD3100, Allogeneic Stem Cell Transplantation)
Withdrawn
- Acute Myelogenous Leukemia
- Myelodysplastic Syndromes
- AMD3100
- Allogeneic Stem Cell Transplantation
- (no location specified)
Feb 10, 2014
Leukemia Trial in United States (biological, drug, procedure, radiation)
Terminated
- Leukemia
- therapeutic allogeneic lymphocytes
- +5 more
-
Phoenix, Arizona
- +82 more
Mar 5, 2015
Acute Myeloid Leukemia, AML1-ETO Fusion Protein Expression Trial in Shanghai (Fludarabine, Cytarabine)
Unknown status
- Acute Myeloid Leukemia
- AML1-ETO Fusion Protein Expression
-
Shanghai, ChinaDepartment of Hematology, Changhai Hospital
Dec 27, 2013
Leukemia Trial in Canada, United States (filgrastim, sargramostim, cytarabine)
Completed
- Leukemia
- filgrastim
- +4 more
-
Mobile, Alabama
- +89 more
Mar 5, 2015
Leukemia, MDS Trial in Israel, United States (filgrastim, sargramostim, cytarabine)
Completed
- Leukemia
- Myelodysplastic Syndromes
- filgrastim
- +5 more
-
Scottsdale, Arizona
- +91 more
Jun 1, 2015
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Chicago (Ara-C, Mitoxantrone, Etoposide)
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Ara-C
- +2 more
-
Chicago, IllinoisThe University of Chicago
Jan 16, 2014
Acute Myeloid Leukemia, MDS Trial in Singapore (CD8+ T-cell depleted donor lymphocyte infusion)
Unknown status
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- CD8+ T-cell depleted donor lymphocyte infusion
-
Singapore, SingaporeDepartment of Hematology-Oncology, National University Hospital
Jan 7, 2014
Acute Myeloid Leukemia Trial in Nimes (Chemotherapy (DAUNORUBICINE-CYTARABINE))
Completed
- Acute Myeloid Leukemia
- Chemotherapy (DAUNORUBICINE-CYTARABINE)
-
Nimes, FranceService Hematologie Oncologie
Dec 19, 2013
Malignant Diseases, Non-malignant Diseases Trial in Palo Alto (CliniMACS CD34+ cell enrichment and T-cell depletion)
Unknown status
- Malignant Diseases
- Non-malignant Diseases
- CliniMACS CD34+ cell enrichment and T-cell depletion
-
Palo Alto, CaliforniaStanford Children's Hospital
May 19, 2015
Leukemia Trial in United States (filgrastim, sargramostim, cytarabine)
Completed
- Leukemia
- filgrastim
- +3 more
-
Mobile, Alabama
- +97 more
Mar 5, 2015
Leukemia Trial in United States (filgrastim, sargramostim, cyclosporine)
Completed
- Leukemia
- filgrastim
- +4 more
-
Mobile, Alabama
- +96 more
Mar 5, 2015
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +12 more
- Lenalidomide
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 22, 2014
Leukemia Trial in Canada, United States (biological, drug, procedure)
Completed
- Leukemia
- filgrastim
- +6 more
-
Birmingham, Alabama
- +19 more
Jul 24, 2014
Hematopoietic Stem Cell Transplantation Trial in Seoul (Busulfan)
Unknown status
- Hematopoietic Stem Cell Transplantation
-
Seoul, Daehangno, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Nov 17, 2013
MDS, Acute Myelogenous Leukemia Trial in Germany (Azacitidine, Lenalidomide)
Terminated
- Myelodysplastic Syndromes
- Acute Myelogenous Leukemia
-
Dresden, Germany
- +3 more
Dec 17, 2013
Acute Myeloid Leukemia Trial in Münster (triple kinase inhibitor BIBF1120)
Unknown status
- Acute Myeloid Leukemia
- triple kinase inhibitor BIBF1120
-
Münster, GermanyUniversitätsklinikum Münster, Medizinische Klinik und Poliklinik
Dec 10, 2013
Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +9 more
- fludarabine phosphate
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Dec 16, 2014
Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid
Completed
- Adult Acute Erythroid Leukemia (M6)
- +17 more
-
Rochester, MinnesotaMayo Clinic
Apr 30, 2014
Infection Trial in Cardiff (sargramostim, liposomal amphotericin B)
Completed
- Infection
- sargramostim
- liposomal amphotericin B
-
Cardiff, Wales, United KingdomUniversity of Wales College of Medicine
Dec 3, 2013
Hematologic Malignancy, Myelodysplastic Syndrome (MDS), Aplastic Anemia Trial in Durham (haplo/cord transplant)
Completed
- Hematologic Malignancy
- +2 more
- haplo/cord transplant
-
Durham, North CarolinaDuke University Medical Center Pediatric Blood and Marrow Transp
Mar 16, 2015
MDS, Secondary Acute Myeloid Leukemia Trial in Worldwide (Reduced Intensity Conditioning, Myeloablative conditioning)
Terminated
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia
- Reduced Intensity Conditioning
- Myeloablative conditioning
-
Düsseldorf, Germany
- +13 more
Apr 2, 2015